Tumor-inhibiting ruthenium complexes are presented as potential anti-c
ancer drugs. Their galenic formulations are given and hydrolytic react
ions are highlighted. Interactions of Ru(III) complexes with serum pro
tein and with oligo- and polynucleotides are discussed.